Metoprolol fumarate

富马酸美托洛尔

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameMetoprolol fumarate
Drug Alias NameMetoprololi FumarasMetoros LSMetorosCGP-2175C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsMultiple TraumaDiabetes Mellitus, Type 2beta-Thalassemia +[19
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenRussian Federation +[9
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPending
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active IndicationsST Elevation Myocardial InfarctionNon-ST Elevated Myocardial InfarctionMyocardial Infarction
Inactive IndicationsMultiple TraumaDiabetes Mellitus, Type 2beta-Thalassemia +[16

Other Information

ATC CodeC07AB02